Coronary artery disease in primary biliary cirrhosis: A systematic review and meta-analysis of observational studies

Hepatology Research

Volumn 45, Issue 11, 2015, Pages 1055-1061

  Ungprasert, Patompong ^a,c   Wijarnpreecha, Karn ^d   Ahuja, Wasin ^e   Spanuchart, Ittikorn ^b   Thongprayoon, Charat ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Coronary artery disease; Epidemiology; Meta analysis; Primary biliary cirrhosis

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; HUMAN; INCIDENCE; OBSERVATIONAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84988223680     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12452     Document Type: Article

References (30)

1. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25: 1776-1785.
2. Ait-Oufella H, Sage AP, Mallat Z etal. Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 2014; 114: 1640-1660.
3. Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 2009; 48: 11-22.
4. Rho YH, Chung CP, Oeser A etal. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010; 62: 1473-1480.
5. Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in atherosclerotic plaque through interferon-alpha. Circulation 2006; 114: 2482-2489.
6. Hansen S, Lassig G, Pistrosch E, Passauer J. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 2003; 170: 177-180.
7. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010; 30: 5-6; 8-9.
8. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
9. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabreil SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-732.
10. Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease and giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2014; doi: 10.1016/j.semarthrit.2014.10.010. [Epub ahead of print].
11. Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 2014; 33: 1099-1104.
12. Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 2014; 44: 63-67.
13. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
14. Metcalf JV, Bhopal RS, Gray J etal. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne. Engl Int J Eoidemiol 1997; 26: 830-836.
15. Pares A, Rodes J. Natural history of primary biliary cirrhosis. Clin Liver Dis 2003; 7: 779-794.
16. Agorastos J, Fox C, Harry DS etal. Lecitin-cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice. Clin Sci Mol Med 1978; 54: 369-379.
17. Jahn CE, Schaefer EJ, Taam LA etal. Lipoprotein abnormalities in primary biliary cirrhosis. Gastroenterology 1985; 89: 1266-1278.
18. Gylling H, Farkkila M, Vuoristo M etal. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein level and their kinetics. Hepatology 1995; 21: 89-95.
19. Chang PY, Lu SC, Su TC etal. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 2004; 45: 2116-2122.
20. Rosenson RS, Baker AL, Chow MJ, Hay RV. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990; 98: 1351-1357.
21. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
24. Van Dam GM, Gips CH. Primary biliary cirrhosis in the Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol 1997; 32: 77-83.
25. Crippin JS, Lindor KD, Jorgensen R etal. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992; 15: 858-862.
26. Longo M, Crosignani A, Battezzati PM etal. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002; 51: 265-269.
27. Solaymani-Dodaran M, Aithal GP, Card T, West J. Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study. Am J Gastroenterol 2008; 103: 2784-2788.
28. Doycheva I, Chen C, Pan JJ, Levy C. Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease. World J Hepatol 2011; 3: 93-98.
29. Zöller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS ONE 2012; 7: e33442.
30. Sorokin A, Brown JL, Thompson PD. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis 2007; 194: 293-299.